Haemoglobinopathies
- Include α-thalassaemia, β-thalassaemia, sickle cell disease and other haemoglobin variant conditions
- Haemoglobinopathy carrier testing should be discussed as part of pre-pregnancy/prenatal care in the
following individuals: - Family history of anaemia/thalassaemia/abnormal haemoglobin variant
- From any of the following ethnic backgrounds: Southern European, Middle Eastern, African, Chinese, South-East Asian, Indian subcontinent, Pacific Islander, New Zealand Maori, South American and some northern Western Australian and Northern Territory Indigenous communities
- Partners of any of the above at-risk patients
- MCV <81fL or MCH < 27pg
- If abnormal blood tests, refer to Genetics Services and/or haematology clinic for genetic counselling and
testing. This is particularly urgent for pregnant couples.
Interpretation of haemoglobinopathy carrier testing results
MCH (pg) |
Ferritin |
Haemoglobin electrophoresis |
Interpretation |
| > or = 27 | Normal | Normal | Thalassaemia unlikely but one-gene deletion α-thalassaemia not excluded |
| Normal | Hbs present | Carrier for sickle cell disease | |
| Low | Normal | Reduced iron stores or iron deficiency, thalassaemia unlikely but one-gene deletion α-thalassaemia not excluded | |
| <27 | Normal | HbA2 increased HbH present |
Carrier for β-thalassaemia |
| HbA2 normal HbH present |
Carrier for α-thalassaemia | ||
| HbS present | Carrier for sickle cell disease Possible co-existent thalassaemia carrier state |
||
| Normal | Possible carrier for α-thalassaemia DNA testing indicated |
||
| Low | Normal | Iron deficiency Thalassaemia may coexist If woman is pregnant, seek advice about DNA testing; test partner for full haemoglobinopathy screen |


